UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q ——————— ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-28508 ——————— AVADEL PHARMACEUTICALS PLC (Exact name of registrant as specified in its charter) ——————— (State or Other Ju ...

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q1 2021 Earnings Conference Call May 10, 2021 8:30 AM ET Company Participants Tom McHugh - Chief Financial Officer Greg Divis - Chief Executive Officer Jennifer Gudeman - Vice President of Medical and Clinical Affairs Richard Kim - Chief Commercial Officer Conference Call Participants Paul Matteis - Stifel David Amsellem - Piper Sandler Francois Brisebois - Oppenheimer Madhu Yennawar - SVB Leerink David Sherman - Lifesci Capital Robin Garner - Craig-Hallum Oren Livna ...

Start Time: 08:30 January 1, 0000 9:25 AM ET Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q4 2020 Earnings Conference Call March 09, 2021, 08:30 AM ET Company Participants Greg Divis - CEO Thomas McHugh - CFO Richard Kim - Chief Commercial Officer Jennifer Gudeman - VP of Medical and Clinical Affairs Conference Call Participants Eason Lee - SVB Leerink Thor Nagel - Stifel David Amsellem - Piper Jaffray Francois Brisebois - Oppenheimer David Sherman - Lifesci Capital Matthew Kaplan - Ladenburg Thalmann Robin Gar ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period ____________ to ____________ Commission file number: 000-28508 AVADEL PHARMACEUTICALS PLC (Exact name of registrant as specified in its charter) Ireland 98-1341933 State or other ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q ——————— ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-28508 ——————— AVADEL PHARMACEUTICALS PLC (Exact name of registrant as specified in its charter) ——————— (State or Oth ...

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q3 2020 Earnings Conference Call November 9, 2020 8:30 AM ET Company Participants Thomas McHugh - CFO Greg Divis - CEO Conference Call Participants David Amsellem - Piper Sandler Paul Matteis - Stifel Francois Brisebois - Oppenheimer Matt Kaplan - Ladenburg Operator Greetings. Welcome to Avadel Pharmaceuticals Third Quarter 2020 Earnings Call. [Operator Instructions] Please note, this conference is being recorded. I will now turn the conference over to your host Tom ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q ——————— ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-28508 ——————— AVADEL PHARMACEUTICALS PLC (Exact name of registrant as specified in its charter) ——————— Ireland 000-28508 ...

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q2 2020 Earnings Conference Call August 10, 2020 8:30 AM ET Company Participants Thomas McHugh - Chief Financial Officer Greg Divis - Chief Executive Officer Jordan Dubow - Chief Medical Officer Conference Call Participants Ami Fadia - Leerink Paul Matteis - Stifel Francois Brisebois - Craig-Hallum Capital Group David Amsellem - Piper Jaffray Operator Greetings, and welcome to the Avadel Pharmaceuticals Second Quarter 2020 Earnings Conference Call. At this time, all ...